|
Insurance & Litigation
•
|
Tools & Information
•
•
•
|
|
 Back to New York Times Health News Archives
New York Times Health News: 12-06-2004
Critics say the F.D.A.'s efforts to monitor the ill effects of drugs that are on the market are a shadow of what they should be.
Among health care experts there is a surprising consensus that the U.S. must inevitably adopt some kind of universal coverage.
A major clinical trial found that children with sickle cell disease who are at high risk of having strokes should continue to be treated with periodic blood transfusions.
Many experts are concerned that the new Medicare law will be unworkable for most Americans who live in nursing homes.
While rimonabant sounds like a dream come true to people who are trying to lose weight, some researchers say the drug may be getting more attention than it deserves.
Was it the fog of a late-40's brain or something more serious? The author's scientific journey in pursuit of her memory.
|
|
